These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20011933)

  • 1. [Estimation of coronary heart disease risk in Chilean subjects based on adapted Framingham equations].
    Icaza G; Núñez L; Marrugat J; Mujica V; Escobar MC; Jiménez AL; Pérez P; Palomo I
    Rev Med Chil; 2009 Oct; 137(10):1273-82. PubMed ID: 20011933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.
    Marrugat J; Subirana I; Comín E; Cabezas C; Vila J; Elosua R; Nam BH; Ramos R; Sala J; Solanas P; Cordón F; Gené-Badia J; D'Agostino RB;
    J Epidemiol Community Health; 2007 Jan; 61(1):40-7. PubMed ID: 17183014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study].
    Aranceta J; Pérez Rodrigo C; Foz Sala M; Mantilla T; Serra Majem L; Moreno B; Monereo S; Millán J;
    Med Clin (Barc); 2004 Nov; 123(18):686-91. PubMed ID: 15563815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
    Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
    Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.
    Lee ET; Howard BV; Wang W; Welty TK; Galloway JM; Best LG; Fabsitz RR; Zhang Y; Yeh J; Devereux RB
    Circulation; 2006 Jun; 113(25):2897-905. PubMed ID: 16769914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a population coronary disease predictive system: the CASSANDRA model.
    Grau M; Subirana I; Vila J; Elosua R; Ramos R; Sala J; Dégano IR; Tresserras R; Bielsa O; Marrugat J
    J Epidemiol Community Health; 2014 Nov; 68(11):1012-9. PubMed ID: 24619990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary risk estimation in Spain using a calibrated Framingham function].
    Marrugat J; Solanas P; D'Agostino R; Sullivan L; Ordovas J; Cordón F; Ramos R; Sala J; Masià R; Rohlfs I; Elosua R; Kannel WB
    Rev Esp Cardiol; 2003 Mar; 56(3):253-61. PubMed ID: 12622955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of the Framingham-Wilson coronary risk equation for the population of Navarra (RICORNA).
    González-Diego P; Moreno-Iribas C; Guembe MJ; Viñes JJ; Vila J
    Rev Esp Cardiol; 2009 Aug; 62(8):875-85. PubMed ID: 19706243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of subjects at high risk of coronary disease in a working population using a prediction model].
    Laurier D; Chau NP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1569-75. PubMed ID: 8745990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting.
    Marín A; Medrano MJ; González J; Pintado H; Compaired V; Bárcena M; Fustero MV; Tisaire J; Cucalón JM; Martín A; Boix R; Hernansanz F; Bueno J
    BMC Public Health; 2006 Feb; 6():38. PubMed ID: 16503965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
    Cooper JA; Miller GJ; Humphries SE
    Atherosclerosis; 2005 Jul; 181(1):93-100. PubMed ID: 15939059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.
    Marrugat J; D'Agostino R; Sullivan L; Elosua R; Wilson P; Ordovas J; Solanas P; Cordón F; Ramos R; Sala J; Masiá R; Kannel WB
    J Epidemiol Community Health; 2003 Aug; 57(8):634-8. PubMed ID: 12883073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE.
    Palmieri L; Donfrancesco C; Giampaoli S; Trojani M; Panico S; Vanuzzo D; Pilotto L; Cesana G; Ferrario M; Chiodini P; Sega R; Stamler J
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):562-70. PubMed ID: 16874146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil.
    Barros ZM; de Alencar Ximenes RA; Miranda-Filho DB; de Albuquerque Mde F; Melo HR; Carvalho EH; Gelenske T; Diniz G; Bandeira F
    Metab Syndr Relat Disord; 2010 Dec; 8(6):489-97. PubMed ID: 20973693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.